Sickle cell disease is the most common hereditary disease in the U.S., affecting approximately 100,000 Americans. Specially matched blood is often used for sickle cell patients in need.
To protect our staff and donors, masks are required when presenting to donate.
In most cases, there is no deferral period for blood donation after receiving a COVID-19 vaccine.
The grant will be used to complete a five-year research project...
Congratulations to Connie Westhoff, PhD, NYBCe Executive Scientific Director, Immunohematology...
Recent results of the AMP trials showed the feasibility of blocking HIV with bimonthly infusions of broadly neutralizing monoclonal antibodies.
According to existing research, the vaccines create enough antibodies to fight the disease
The new building will anchor and grow NYC’s life science ecosystem
We are very pleased to acknowledge the revised FDA guidelines addressing the urgent need for blood during the COVID-19 pandemic.
Fox 5 Good Day NY's recent segment highlighted the lifesaving power of convalescent plasma donation for critical COVID-19 patients.
Study shows the potential of plasma infusions to help save the lives of critically ill COVID-19 patients.
The grant will fund research into the impact of transfusions in patients with sickle cell disease and how to improve transfusion management.
Can’t donate blood? You can still support our mission by contributing a financial gift.